Results 31 to 40 of about 89,275 (314)

Selective Serotonin Re-uptake Inhibitors: An Overview

Psychiatry and Clinical Psychopharmacology, 2021
Over the past decade there has been a crescendo of interest in the role of the serotonin system in mediating both anxiety and depressive disorders. Researchs has provided therapeutic compounds that are selective for re-uptake blockade in the serotonin ...
İsmail ÇİFTER
doaj  

Duloxetine-induced rapid eye movement sleep behavior disorder: a case report

BMC Psychiatry, 2017
Background Tricyclic antidepressants and selective serotonin reuptake inhibitors have been reported to induce the symptoms of rapid eye movement (REM) sleep behavior disorder (RBD) or to exacerbate REM sleep without atonia.
Lu Tan, Junying Zhou, Linghui Yang, Rong Ren, Ye Zhang, Taomei Li, Xiangdong Tang   +6 more
doaj   +1 more source

Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A meta-analysis of randomised controlled treatment trials [PDF]

, 2006
Small studies have shown positive effects from adding a variety of antipsychotic agents in patients with obsessive–compulsive disorder who are unresponsive to treatment with serotonin reuptake inhibitors. The evidence, however, is contradictory.
Carey, P, Denys, D, Fineberg, N, Premkumar, P, Seedat, S, Sivakumaran, T, Stein, DJ, Vythilingum, B, Westenberg, H   +8 more
core   +1 more source

Pharmacokinetics and Pharmacodynamics: A Comprehensive Analysis of the Absorption, Distribution, Metabolism, and Excretion of Psychiatric Drugs

Pharmaceuticals
The two main classifications of antidepressant medications are selective norepinephrine reuptake inhibitors (SNRIs) and selective serotonin reuptake inhibitors (SSRIs).
Zainab Zakaraya, Mohammad Abu Assab, Lina N. Tamimi, Nida Karameh, Mohammad Hailat, Laila Al-Omari, Wael Abu Dayyih, Omar Alasasfeh, Mohammad Awad, Riad Awad   +9 more
doaj   +1 more source

Data on the impact of SSRIs and depression symptoms on the neural activities in obsessive–compulsive disorder at rest

Data in Brief, 2016
The data provided here related to our research article (Chen et al., 2016) [1]. We provide whole-brain intrinsic functional connectivity patterns in obsessive–compulsive disorder at resting-state [1].
Yunhui Chen, Michal Juhas, Andrew J Greenshaw, Qiang Hu, Xin Meng, Hongsheng Cui, Yongzhuo Ding, Lu Kang, Yubo Zhang, Yuhua Wang, Guangcheng Cui, Ping Li   +11 more
doaj   +1 more source

Latest updates on the serotonergic system in depression and anxiety

Frontiers in Synaptic Neuroscience, 2023
Psychiatric disorders are among the leading causes of global health burden, with depression and anxiety being the most disabling subtypes. The two common disorders, depression and anxiety, usually coexist and are pathologically polygenic with complicated
Jianwen Lin, Wenxin Liu, Wenxin Liu, Jing Guan, Jing Guan, Jing Guan, Jianing Cui, Ruolin Shi, Lu Wang, Dong Chen, Yi Liu, Yi Liu   +11 more
doaj   +1 more source

Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects [PDF]

, 2004
Reboxetine is a selective noradrenaline reuptake inhibitor, whereas mirtazapine acts as an antagonist at noradrenergic alpha(2), serotonin (5-HT2), 5-HT3 and histamine H-1 receptors.
Baghai, Thomas C., Laakmann, G., Schule, C.   +2 more
core   +1 more source

Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder

Clinics, 2012
OBJECTIVES: Approximately 40-60% of obsessive-compulsive disorder patients are nonresponsive to serotonin reuptake inhibitors. Genetic markers associated with treatment response remain largely unknown.
Fábio M. Corregiari, Márcio Bernik, Quirino Cordeiro, Homero Vallada   +3 more
doaj   +1 more source

Serotonin and motherhood: From molecules to mood [PDF]

, 2019
Emerging research points to a valuable role of the monoamine neurotransmitter, serotonin, in the display of maternal behaviors and reproduction-associated plasticity in the maternal brain.
Li, Ming, Lonstein, Joseph S., Pawluski, Jodi L.   +2 more
core   +3 more sources

Extrapyramidal symptoms and antidepressants – A systematic review

Telangana Journal of Psychiatry
Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclic antidepressants have all been implicated, albeit to varying extents, in precipitating extrapyramidal symptoms.
Ankit Halder, Disha Maity, Satrajit Ghosal, Ashwini Lad   +3 more
doaj   +1 more source